Condition
Ischemic Attack
Total Trials
5
Recruiting
0
Active
0
Completed
5
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 5 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 1 (1)
Trial Status
Completed5
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT03688815Completed
Dipyridamole Induced Ischemia and Biomarkers
NCT02722720Not ApplicableCompleted
Carotid Arteries Stenting Complications: Transradial Approach Versus Transfemoral
NCT03162588Phase 1CompletedPrimary
Multiple Burrhole Therapy With Erythropoietin for Unstable Moyamoya
NCT01955642Completed
Evaluation of the Biological Response to Clopidogrel in Patients With Ischemic Stroke
NCT01706133Not ApplicableCompleted
An Intervention for Elderly in Emergency Services
Showing all 5 trials